3 news items
Acurx Pharmaceuticals, Inc. Reports First Quarter 2024 Results and Provides Business Update
ACXP
15 May 24
Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result
Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific Conference
ACXP
2 May 24
within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward
Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific Conference
ACXP
25 Apr 24
Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result
- Prev
- 1
- Next